Suppr超能文献

造影剂超敏反应:一项意大利的大型长期随访研究

Contrast Medium Hypersensitivity: A Large Italian Study with Long-Term Follow-Up.

作者信息

Nucera Eleonora, Parrinello Giuseppe, Gangemi Sebastiano, Buonomo Alessandro, Aruanno Arianna, Lohmeyer Franziska Michaela, Inchingolo Riccardo, Rizzi Angela

机构信息

UOSD Allergologia e Immunologia Clinica, Dipartimento Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.

出版信息

Biomedicines. 2022 Mar 24;10(4):759. doi: 10.3390/biomedicines10040759.

Abstract

Hypersensitivity reactions (HRs) to contrast media (CM) are a major problem. We compared differences of HRs to iodinated contrast media (ICM) versus gadolinium-based contrast media (GBCM), collecting data on prevalence, type, latency and severity. Secondly, the predisposition to perform new contrast tests, use of premedication and possible appearance of new reactions were explored in a long-term follow-up of 5 years. Clinical data, comorbidities, skin test (ST) results, re-exposure to CM procedures with any new reactions, premedication and CM used were collected. In a retrospective single-center study, 350 patients with mild to moderate HRs were enrolled. Asthma, food allergy, non-allergic drug hypersensitivity and neurologic disease were significantly more frequent in patients with HRs to GBCM compared to the high evidence of cardiovascular disease and history of cancer in patients with HRs to ICM. A marked delay in performing STs was reported by patients with negative results (66 months, p < 0.01). Iomeprol, iopamidol and gadobenic acid were the culprit CM most involved in HRs in patients with positive STs. During follow-up, 7.1% of responders reported new HRs to CM despite negative STs, premedication and infusion of alternative CM in most cases.

摘要

对比剂超敏反应(HRs)是一个主要问题。我们比较了对碘化对比剂(ICM)与钆对比剂(GBCM)的HRs差异,收集了关于患病率、类型、潜伏期和严重程度的数据。其次,在长达5年的长期随访中,探讨了进行新对比剂试验的易感性、预处理的使用以及新反应的可能出现情况。收集了临床数据、合并症、皮肤试验(ST)结果、再次接受对比剂检查时出现的任何新反应、预处理情况以及使用的对比剂。在一项回顾性单中心研究中,纳入了350例轻度至中度HRs患者。与对ICM有HRs的患者中高比例的心血管疾病证据和癌症病史相比,对GBCM有HRs的患者中哮喘、食物过敏、非过敏性药物超敏反应和神经系统疾病更为常见。ST结果为阴性的患者报告进行ST的时间明显延迟(66个月,p <(0.01))。碘普罗胺、碘帕醇和钆贝葡胺是ST结果为阳性的患者中最常导致HRs的对比剂。在随访期间,7.1%的反应者报告尽管ST结果为阴性、进行了预处理且大多数情况下输注了替代对比剂,但仍出现了对对比剂的新HRs。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782a/9028178/e50428edcf3f/biomedicines-10-00759-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验